Approval · Notice of Compliance 32466 · 2024
NORTRIPTYLINE: Notice of Compliance 32466
Issued January 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32466
- Date
- January 5, 2024
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Safety Update to the Product Monograph (PM)
- Canadian reference product
- AVENTYL (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORTRIPTYLINE | Not yet assigned | — |
Medicinal ingredients
- NORTRIPTYLINE HCL 10 MG per CAP
- NORTRIPTYLINE HCL 25 MG per CAP